Dual anti-HLH and antitumor efficacy of golidocitinib in relapsed/refractory PTCL-associated hemophagocytic lymphohistiocytosis: A retrospective safety and activity analysis
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: Sichuan University, West China Hospital of Sichuan University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417005649
Cites:
Cited by:
Related to:
